389 related articles for article (PubMed ID: 1692629)
1. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
Meri S; Pangburn MK
Proc Natl Acad Sci U S A; 1990 May; 87(10):3982-6. PubMed ID: 1692629
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
[TBL] [Abstract][Full Text] [Related]
3. Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H.
Meri S; Pangburn MK
Biochem Biophys Res Commun; 1994 Jan; 198(1):52-9. PubMed ID: 8292049
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides.
Pangburn MK
J Immunol; 1989 Apr; 142(8):2759-65. PubMed ID: 2467938
[TBL] [Abstract][Full Text] [Related]
5. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
[TBL] [Abstract][Full Text] [Related]
6. Localization of the heparin-binding site on complement factor H.
Pangburn MK; Atkinson MA; Meri S
J Biol Chem; 1991 Sep; 266(25):16847-53. PubMed ID: 1832158
[TBL] [Abstract][Full Text] [Related]
7. Species specificity of recognition by the alternative pathway of complement.
Horstmann RD; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1985 Feb; 134(2):1101-4. PubMed ID: 3155536
[TBL] [Abstract][Full Text] [Related]
8. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
[TBL] [Abstract][Full Text] [Related]
9. Analysis of recognition in the alternative pathway of complement. Effect of polysaccharide size.
Pangburn MK
J Immunol; 1989 Apr; 142(8):2766-70. PubMed ID: 2467939
[TBL] [Abstract][Full Text] [Related]
10. Effects of sulphated polyanions on functions of complement factor H.
Koistinen V
Mol Immunol; 1993 Feb; 30(2):113-8. PubMed ID: 8429830
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
Fearon DT
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
[TBL] [Abstract][Full Text] [Related]
12. Guinea pig erythrocytes, after their contact with influenza virus, acquire the ability to activate the human alternative complement pathway through virus-induced desialation of the cells.
Lambré CR; Kazatchkine MD; Maillet F; Thibon M
J Immunol; 1982 Feb; 128(2):629-34. PubMed ID: 6459381
[TBL] [Abstract][Full Text] [Related]
13. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
Fearon DT
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1971-5. PubMed ID: 273923
[TBL] [Abstract][Full Text] [Related]
14. Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement.
Koistinen V
Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):317-9. PubMed ID: 1533511
[TBL] [Abstract][Full Text] [Related]
15. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Oct; 131(4):1930-5. PubMed ID: 6225800
[TBL] [Abstract][Full Text] [Related]
16. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
Johnson E; Eskeland T; Bertheussen K
Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the alternative pathway of human complement by C1q.
Fishelson Z; Müller-Eberhard HJ
Mol Immunol; 1987 Sep; 24(9):987-93. PubMed ID: 2958692
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement.
Pangburn MK; Pangburn KL; Koistinen V; Meri S; Sharma AK
J Immunol; 2000 May; 164(9):4742-51. PubMed ID: 10779780
[TBL] [Abstract][Full Text] [Related]
19. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
Meri S; Pangburn MK
Eur J Immunol; 1990 Dec; 20(12):2555-61. PubMed ID: 2148521
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
Mold C; Kingzette M; Gewurz H
J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
